Colliding Epidemics and the Rise of Cryptococcosis

scientific article published on 23 December 2015

Colliding Epidemics and the Rise of Cryptococcosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/JOF2010001
P932PMC publication ID5753082
P698PubMed publication ID29376920

P2093author name stringChristina C Chang
Sharon C-A Chen
P2860cites workClinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyQ21144623
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsQ24600270
Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeQ24630287
Cryptococcus gattii infectionsQ27002687
Disseminated cryptococcal infection in patient with novel JAK3 mutation severe combined immunodeficiency, with resolution after stem cell transplantation.Q54545681
Unrecognized Pretransplant and Donor‐Derived Cryptococcal Disease in Organ Transplant RecipientsQ57569117
Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United StatesQ59871942
Pulmonary cryptococcosisQ73350386
A case of Cryptococcus neoformans meningoencephalitis complicating Boeck's sarcoidQ74427188
The coincidence of cryptococcosis and disease of the reticulo-endothelial and lymphatic systemsQ75795858
Cryptococcal meningo-encephalitis associated with systemic lupus erythematosusQ79046549
Cryptococcal infection following steroid therapyQ79398228
The poverty of the immunological mechanism in patients with Hodgkin's diseaseQ79602962
Transmission of Cryptococcus neoformans by Organ TransplantationQ83161462
Update on emerging infections: news from the Centers for Disease Control and Prevention. Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010Q83165673
Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic featuresQ87371965
Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndromeQ37247472
Cryptococcus gattii infections in multiple states outside the US Pacific NorthwestQ37261982
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan AfricaQ37265947
Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patientsQ37502649
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomesQ37579943
Opportunistic infection-associated immune reconstitution syndrome in transplant recipients.Q37892236
Organ transplantation: historical perspective and current practice.Q37970998
Current status of islet xenotransplantation.Q38562714
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trialQ38922578
Epidemiologic differences between the two varieties of Cryptococcus neoformansQ39154213
Cryptococcosis in a cancer hospital.Clinical and pathological correlates in forty-six patientsQ39620728
Liver transplantation: where it's been and where it's going.Q39651653
A rare case of Cryptococcus gattii pneumonia in a renal transplant patientQ40169104
Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia.Q40560602
Cryptococcal meningitis presenting with headache and a pustular eruption in a heart transplant patientQ41099935
Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience.Q41189447
A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisQ41644134
Combination antifungal therapy for cryptococcal meningitisQ41924502
Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndromeQ42269599
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trialQ43678311
History of solid organ transplantation and organ donationQ43753832
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials GroupQ44474075
Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.Q44505776
Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.Q44924709
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.Q46012365
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar puncturesQ46091639
The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.Q46172301
The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapyQ46433636
First reported case of cellulitis due to Cryptococcus gattii in lung transplantation recipient: a case reportQ46472416
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipientsQ46503386
Glances at the history of transplantation immunologyQ47717966
The origins of organ transplantationQ48433386
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principleQ28140704
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimenQ28141785
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristicsQ28338447
Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditionsQ28365296
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSQ29617372
Implications of climate change (global warming) for the healthcare systemQ30224617
Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.Q30300307
Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.Q30459073
Invasive fungal infections after natural disastersQ30763683
Cryptococcal meningitis post autologous stem cell transplantationQ30805310
Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approachQ33510243
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Q34020746
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitisQ34024416
Global Warming Will Bring New Fungal Diseases for MammalsQ34030615
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.Q34216198
The discovery and early understanding of leukemiaQ34228042
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsQ34247688
Cyclosporin A in patients receiving renal allografts from cadaver donorsQ34347891
Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.Q34428446
Cryptococcus neoformans: the yeast that likes it hot.Q34525153
Transplantation tolerance from a historical perspectiveQ34572212
Epidemiology of cryptococcal meningitis in the US: 1997-2009.Q34606681
Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforestQ34936939
Cryptococcal meningoencephalitis in a patient with hyper immunoglobulin M (IgM) syndrome: a case reportQ35231358
Fungal infections in renal transplant patientsQ35387111
THE BIOLOGY OF TISSUE TRANSPLANTATION.Q35448382
The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitisQ35635476
Cryptococcosis; a review with special reference to apparent association with Hodgkin's diseaseQ35653132
Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007.Q35877113
Autochthonous and dormant Cryptococcus gattii infections in EuropeQ36318438
Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.Q36692375
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trialQ36806209
The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitisQ36846260
Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapyQ37109543
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectcryptococcosisQ1470140
P577publication date2015-12-23
P1433published inJournal of FungiQ27726983
P1476titleColliding Epidemics and the Rise of Cryptococcosis
P478volume2

Search more.